Meeting requirements for Joint Clinical Assessments:

The European Union’s move toward harmonised health technology assessments (HTAs) is transforming how clinical evidence is evaluated for market access. With Joint Clinical Assessments (JCAs) being phased in under the EU HTA Regulation 2021, developers must adapt to a more coordinated—but complex—review process for HTA submission.

This whitepaper provides a practical roadmap to help sponsors meet JCA requirements efficiently. It touches on critical planning elements such as the PICO framework, real-world evidence (RWE), and multi-country HTA coordination.

Prepare for Joint Clinical Assessments with confidence—whether you're mapping PICO requirements, developing your HTA submission dossier, or supporting value through RWE strategy. Learn how to align internal teams, plan evidence generation, and position your product for faster, more consistent access across Europe.